The multi-specific human 17 beta-hydroxysteroid dehydrogenase type 7: Non-competitive inhibitors can target different catalyses to facilitate breast cancer treatment-Reference-Cited by-同舟云学术

The multi-specific human 17 beta-hydroxysteroid dehydrogenase type 7: Non-competitive inhibitors can target different catalyses to facilitate breast cancer treatment

Published:2021-11 Issue: Volume:214 Page:105963
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Thériault Jean-Francois,Poirier Donald^ORCID,Lin Sheng-Xiang

Funder

Fondation CHU de Québec

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference25 articles.

1. Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7;Torn;Biochem. Biophys. Res. Commun.,2003

2. Synergistic control of sex hormones by 17beta-HSD type 7: a novel target for estrogen-dependent breast cancer;Wang;J. Mol. Cell Biol.,2015

3. Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells;Zhang;J. Steroid Biochem. Mol. Biol.,2015

4. PRAP, a prolactin receptor associated protein: its gene expression and regulation in the corpus luteum;Duan;Endocrinology,1997

5. Expression cloning of a novel estrogenic mouse 17 beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat;Nokelainen;Mol. Endocrinol.,1998

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis;Medical Science Monitor;2021-11-25